Wentworth Kerry 4
4 · Nuvation Bio Inc. · Filed Mar 3, 2026
Insider Transaction Report
Form 4
Wentworth Kerry
CHIEF REGULATORY OFFICER
Transactions
- Award
Stock Option (Right to Buy)
[F2]2026-02-27+748,130→ 748,130 totalExercise: $5.91Exp: 2036-02-26→ Class A Common Stock (748,130 underlying)
Holdings
- 53,000
Class A Common Stock
[F1]
Footnotes (2)
- [F1]Includes 3,000 shares acquired on November 19, 2025 under the 2021 Employee Stock Purchase Plan.
- [F2]Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.
Signature
/s/ Stephen Dang, Attorney-in-Fact|2026-03-03